Jane Ung

This inventor holds 19 USPTO granted patents and 7 published patent applications and 9 EPO patents, primarily in Macrocyclic Compounds. Top assignees: Turning Point Therapeutics, Inc., Senomyx, Inc., Firmenich Incorporated. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jane Ung. Retrieved from https://idiyas.com/inventor/jane-ung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 7)

% Patents Active = 100.0

EPO Patents = 9 (Patent Applications = 14)

Average Co-Inventor Count = 6.6

ph-index = 5

Forward Citations = 74(Granted Patents)

Company Filing History:

10 out of 19

Turning Point Therapeutics, Inc.

Firmenich Incorporated

Tp Therapeutics, Inc.

patents

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Macrocyclic Compounds

TRPM8 Modulators

Chiral Diaryl Macrocycles

Kinase Inhibitors

Disease Treatment

Protein Kinases

Pharmaceutical Applications

Therapeutic Compounds

Modulators

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12606571 - Macrocyclic compounds and uses thereof (2026-04-21),

2. 11981684 - Macrocyclic compounds and uses thereof (2024-05-14),

3. 11634433 - Macrocycles for use in treating disease (2023-04-25),

4. 11286265 - Macrocyclic compounds for treating disease (2022-03-29),

5. 11286264 - Macrocyclic compounds and uses thereof (2022-03-29),

6. 11155563 - Macrocyclic compounds and uses thereof (2021-10-26),

7. 11142533 - Macrocycles for use in treating disease (2021-10-12),

8. 11028052 - Compounds useful as modulators of TRPM8 (2021-06-08),

9. 11008337 - Chiral diaryl macrocycles as modulators of protein kinases (2021-05-18),

10. 10953007 - Compounds useful as modulators of TRPM8 (2021-03-23),

11. 10745416 - Macrocyclic compounds for treating disease (2020-08-18),

12. 10689400 - Macrocycle kinase inhibitors (2020-06-23),

13. 10421727 - Compounds useful as modulators of TRPM8 (2019-09-24),

14. 10392371 - Compounds useful as modulators of TRPM8 (2019-08-27),

15. 10316044 - Chiral diaryl macrocycles as modulators of protein kinases (2019-06-11),

Title: **Innovative Solutions by Jane Ung: A Trailblazer in Cancer Treatment**

Introduction

Jane Ung, a prominent inventor based in San Diego, California, has made significant strides in the field of pharmaceutical innovations. With a remarkable portfolio of 18 patents, her work primarily focuses on developing compounds aimed at treating cancer. Her contributions stand as a testament to her expertise and dedication to enhancing therapeutic options for patients.

Latest Patents

Among Jane's latest patents are groundbreaking innovations in macrocyclic compounds. One patent discloses "Macrocyclic compounds and uses thereof," which involves certain macrocyclic compounds that inhibit SRC and MET, along with CSFR. This patent outlines pharmaceutical compositions containing such compounds and methods for utilizing them in cancer treatment. Another of her significant contributions is related to "Macrocycles for use in treating disease," which covers chiral diaryl macrocyclic derivatives, pharmaceutical compositions featuring them, and their applications in cancer therapy.

Career Highlights

Throughout her career, Jane Ung has held essential roles in various companies making strides in the pharmaceutical industry. Notable among these is Turning Point Therapeutics, Inc., where she contributed her expertise to advance innovative therapeutic solutions. Additionally, her tenure at Senomyx, Inc. has showcased her ability to blend creativity with scientific research, further bolstering her reputation as an inventor.

Collaborations

Jane has collaborated with distinguished professionals in her field, including her coworkers Jingrong Jean Cui and Evan W Rogers. These partnerships highlight her commitment to teamwork and collective innovation, driving forward her impactful research in pharmaceutical solutions for cancer treatment.

Conclusion

Jane Ung's contributions to the field of medicine through her innovative patents exemplify her role as a trailblazer in cancer therapy. By focusing on macrocyclic compounds and their application in treating disease, she continues to push the boundaries of pharmaceutical research. Her collaboration with other experts only enhances the potential impact of her work, marking her as a significant figure in the realm of inventions and innovation.

Profile summary based on public USPTO records.